- Home
- HAFC vs PSNL Comparison
HAFC vs PSNL Comparison
Compare HAFC & PSNL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | HAFC | PSNL |
|---|---|---|
| Founded | 1982 | 2011 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Major Banks | Medical Specialities |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 770.0M | 729.1M |
| IPO Year | 2000 | 2019 |
Fundamental Metrics
Financial Performance| Metric | HAFC | PSNL |
|---|---|---|
| Price | $25.72 | $7.18 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 3 | 6 |
| Target Price | ★ $31.33 | $11.50 |
| AVG Volume (30 Days) | 212.8K | ★ 1.3M |
| Earning Date | 04-21-2026 | 05-05-2026 |
| Dividend Yield | ★ 4.44% | N/A |
| EPS Growth | 22.44 | ★ 33.58 |
| EPS | ★ 2.51 | N/A |
| Revenue | ★ $270,165,000.00 | $69,648,000.00 |
| Revenue This Year | $18.65 | $16.94 |
| Revenue Next Year | $7.28 | $36.58 |
| P/E Ratio | $10.06 | ★ N/A |
| Revenue Growth | ★ 15.28 | N/A |
| 52 Week Low | $19.25 | $2.83 |
| 52 Week High | $30.20 | $11.50 |
Technical Indicators
Market Signals| Indicator | HAFC | PSNL |
|---|---|---|
| Relative Strength Index (RSI) | 44.42 | 41.03 |
| Support Level | $24.44 | $6.89 |
| Resistance Level | $27.04 | $9.64 |
| Average True Range (ATR) | 0.71 | 0.62 |
| MACD | 0.01 | -0.11 |
| Stochastic Oscillator | 48.82 | 21.91 |
Price Performance
Historical ComparisonAbout HAFC Hanmi Financial Corporation
Hanmi Financial Corp is a Los Angeles-based bank that caters to Korean-Americans and other multi-ethnic communities across California, Colorado, Georgia, Illinois, New Jersey, New York, Texas, Virginia, and Washington. The bank mainly focuses on small businesses and commercial and real estate loans. It also offers a variety of international finance and trade services and products, including letters of credit, import financing, and export financing. The Bank's revenues are derived from interest and fees on loans, interest, and dividends on the securities portfolio, service charges on deposit accounts, and sales of SBA loans.
About PSNL Personalis Inc.
Personalis Inc is a provider of genomic sequencing and analytics solutions to support the development of personalized cancer vaccines and other next-generation cancer immunotherapies. It has one segment, the sale of sequencing and data analysis services. Its products include ImmunoID NeXT, NeXT Personal, NeXT Dx Test, and other pharma research solutions.